Jeffrey Soar

Prof. Jeffrey Soar

orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
SYSalifu Yusif
Salifu Yusif
Jeffrey SoarJeffrey Soar
Jeffrey Soar
AHAbdul Hafeez-Baig
Abdul Hafeez-Baig

10 February 2023 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
EHElias Hossain
Elias Hossain
RRRajib Rana
Rajib Rana
NHNiall Higgins
Niall Higgins
Jeffrey SoarJeffrey Soar
Jeffrey Soar
PBPrabal Datta Barua
Prabal Datta Barua
KTKathryn Turner
Kathryn Turner

1 November 2016 in Computers in Human Behavior
Verified
Journal Article
Closed access
AAAhmed Younis Alsabawy
Ahmed Younis Alsabawy
ACAileen Cater-Steel
Aileen Cater-Steel
Jeffrey SoarJeffrey Soar
Jeffrey Soar

1 December 2018 in International Journal of Information Management
Verified
Journal Article
Closed access
OAOmar Ali
Omar Ali
Anup ShresthaAnup Shrestha
Anup Shrestha
Jeffrey SoarJeffrey Soar
Jeffrey Soar
SWSamuel Fosso Wamba
Samuel Fosso Wamba

4 January 2023 in Renewable Energy
Verified
Journal Article
Closed access
LJLionel P. Joseph
Lionel P. Joseph
Ravinesh DeoRavinesh Deo
Ravinesh Deo
RPRamendra Prasad
Ramendra Prasad
SSSancho Salcedo-Sanz
Sancho Salcedo-Sanz
NRNawin Raj
Nawin Raj
Jeffrey SoarJeffrey Soar
Jeffrey Soar

23 October 2021 in Sensors
Verified
Journal Article
Open access
PDF file
HLHui Wen Loh
Hui Wen Loh
WHWanrong Hong
Wanrong Hong
COChui Ping Ooi
Chui Ping Ooi
Subrata ChakrabortySubrata Chakraborty
Subrata Chakraborty
Prabal Datta BaruaPrabal Datta Barua
Prabal Datta Barua
U Rajendra AcharyaU Rajendra Acharya
U Rajendra Acharya
Parkinson’s disease (PD) is the second most common neurodegenerative disorder affecting over 6 million people globally. Although there are symptomatic treatments that can increase the survivability of the disease, there are no curative treatments. The prevalence of PD and disability-adjusted life years continue to increase steadily, leading to a growing burden on patients, their families, society and the economy. Dopaminergic medications can significantly slow down the progression of PD when applied during the early stages. However, these treatments often become less effective with the disease progression. Early diagnosis of PD is crucial for immediate interventions so that the patients can remain self-sufficient for the longest period of time possible. Unfortunately, diagnoses are often late, due to factors such as a global shortage of neurologists skilled in early PD diagnosis. Computer-aided diagnostic (CAD) tools, based on artificial intelligence methods, that can perform automated diagnosis of PD, are gaining attention from healthcare services. In this review, we have identified 63 studies published between January 2011 and July 2021, that proposed deep learning models for an automated diagnosis of PD, using various types of modalities like brain analysis (SPECT, PET, MRI and EEG), and motion symptoms (gait, handwriting, speech and EMG). From these studies, we identify the best performing deep learning model reported for each modality and highlight the current limitations that are hindering the adoption of such CAD tools in healthcare. Finally, we propose new directions to further the studies on deep learning in the automated detection of PD, in the hopes of improving the utility, applicability and impact of such tools to improve early detection of PD globally.